Synaffix Expands Partnership Horizon with Boehringer Ingelheim
January 9, 2025 - 17:10
In a significant move to enhance its portfolio, Synaffix, a leader in antibody-drug conjugate (ADC) technology, has entered into a new licensing agreement with Boehringer Ingelheim. This partnership allows Boehringer to leverage Synaffix's advanced ADC technologies for a specified number of cancer targets, although the exact details regarding the number of targets remain confidential.
This agreement marks a strategic step for Synaffix as it continues to build on its momentum from last year, when it secured several partnerships. Additionally, Synaffix has expanded its collaboration network by forming a technology licensing deal with Mitsubishi Tanabe Pharma in Japan. These developments underscore Synaffix's commitment to advancing cancer treatment options through innovative ADC technologies.
As the landscape of cancer therapeutics evolves, this collaboration with Boehringer Ingelheim is poised to accelerate the development of novel ADC therapies, potentially leading to more effective treatment solutions for patients battling cancer.
MORE NEWS
July 4, 2026 - 00:42
BlackSky Technology (BKSY) Is Up 14.5% After Major NRO Contract Expansion And Equity-Paid BoardBlackSky Technology saw its stock price surge 14.5 percent in late June 2026 after the company announced a significant expansion of its contract with the National Reconnaissance Office. The updated...
July 3, 2026 - 02:30
Intel, Marvell Technology, and AMD Stocks Trade Down, What You Need To KnowA broad selloff hit semiconductor stocks in afternoon trading Thursday, with shares of Intel, Marvell Technology, and AMD all trading lower. The decline came as investors grew cautious over signs...
July 2, 2026 - 21:46
Who’s Regulating Police Technology? It’s Not the Courts.Public institutions are quietly handing over the authority to regulate policing technology to private industry, according to Texas A&M University School of Law professor Hannah Bloch-Wehba. In a...
July 2, 2026 - 04:52
Culture Pick | ‘Toy Story 5’ explores tension between toys, technologyThe latest chapter in the beloved animated franchise hit theaters on June 19, and it did not disappoint at the box office. `Toy Story 5,` directed by Pixar veteran Andrew Stanton, earned $312...